ACRV vs BIIB: Which Stock is Better?
Side-by-side comparison of Acrivon Therapeutics Inc and Biogen Inc in 2026
ACRV
Acrivon Therapeutics Inc
$1.96
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | ACRV | BIIB | Winner |
|---|---|---|---|
| Market Cap | $61.85M | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | 0.0% | 0.0% | BIIB |
| Gross Margin | 0.0% | 76.6% | BIIB |
Analyze ACRV
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRV or BIIB a better investment?
Comparing ACRV and BIIB: Acrivon Therapeutics Inc has a market cap of $61.85M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRV and BIIB?
ACRV (Acrivon Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRV or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRV or BIIB?
BIIB has higher revenue growth at 0.0% vs 0.0% for ACRV.
Which company is more profitable: ACRV or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to 0.0% for ACRV.
Which is the larger company: ACRV or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $61.85M for ACRV.
Should I buy ACRV or BIIB in 2026?
Both ACRV and BIIB have investment merit. ACRV trades at $1.96 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRV and BIIB stock?
Key differences: Market Cap ($61.85M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 76.6%).